-
8/9/2019 Nurani Kaeda- Part 1
1/5
*f tr:P3"\ $qb ',f-'l#;E & ffii** ,q_F# =oq_3
#"'l'i,'r!&-r'ru| t, srLlilgJ=_----
Ga'bgr0&&Til"":i:t:,':'.ffi:== -.==,,=.
r)o,",iti^"x,."";." .,0,,,"
"ff:il:j:H,:":::eretsor;;; ;",,";, ;,rr;," USp '1b0 mg,
Folic Acid usP 500 mcg & Zinc sulphate Monohydrate usP 61 .8
mg (Eq to 22.5 mg zinc):::=:r--=:r.:-=: ferozi is indicated for the
treatment and prophylaxis of iron, folic acid and zinc deficiency,
especially duringpregnancy and lactation.:=--=:::r==:-:li+-=::r:*=:
Hypersensitivity to any component of the drug.=r=:===* c::*
=*ii:i=i*irsii*-: '1 capsule daily throughout pregnancy and
lactation or as directed by the physician..i.=u'*:-:--** *ff**ts:
Dark stools are usual during iron therapy and nausea and other
symptoms of gastro-intestinal irritation,such as anorexia,
vomiting, constipation and diarrhea are sometimes
encountered.frrtti spansule capsules are designedto reduce the
possibility of gasko intestinal irritation.F:.e*a*ii*$li:
Absorption of iron may be impaired by penicillamine and by
antacids. Such poteniial interactions can bereduced by separating
administration of each product by severa! hours.F**king: Each box
contains 10 X 10's capsules in blister pack'
DRUG INTERNATIONAL LIMITEDTongi-Gazipur Better life through
better rnedicine
-
8/9/2019 Nurani Kaeda- Part 1
2/5
l,*1 i irbiu*rlffi'*l.,*'i -t i -i" Gle.-if*.j__*.*J* I
-j----f-*--f-l-i ..r]' j-J I l.') I "'l i 'it '4 i { i .,{'i rll%T-
"61 ir"ri\-t
"& i 'q
V* 4i,_4 14'_"1*tt=g-*
t,. 4iiAlirf)
!1 i t!*l i ,"! iii'i .l I-'-]i
-
8/9/2019 Nurani Kaeda- Part 1
3/5
"1tt'fi-snfj
:Re{InJ^i..;;
*q\ - I\i .l\I ? | : :L\T['--t i \' -"lpllI**- _-._--t_*-_*i JrJ
*i*ii T
-
8/9/2019 Nurani Kaeda- Part 1
4/5
** i{\
y3. l\t\ l\/'i
\J.rJ"'t" rt\{r
v9 -1r;.nv i ' ',)$J 3\*i-i 'jL " L -*ij:-f "'.3_i-',:.{}h*'ii
xi w'iiff ii. i:&:
\$**q>^-6\-E .5{d}
Th]nJ\;1ri)i**i$iF,i$l--- *-+---"-+- - -_.t;F); r q ,l\". foi.
iv*, i,{|""m'i; "5 1-f6 ii$i'$T*.3i;F,'jll$*-* _i,tiit?s" . .;s'
tt, ;ru\*.-*\q-*
Y3i: ii '=1.N1 3l* _----i'l-- .-* -j- - -. *i,-
---i.*-.]r-ili-_;;l- a:.]*; 'xrt i hr=3.8 i'e r"u i *$\)il ^,i -. I
it\rr{$ li : lrri "rttt i t\--F- it 'J ,, i )
i-, --f-- *I\"i') i \-\L_*F |-
g) ii "S"l *:ni 's'"-*--.*--+e) il "S"li ----i* ---fti r**
*El\l o5r"ttf"i 1$$ ii nn, I 5ii1 qol =*ii,fi__ I
_-___*rGcdeTat
*-.*,u E
-
8/9/2019 Nurani Kaeda- Part 1
5/5
% l'*.is i*1Ji.r-* ii *.e,;--=j**"-- j"--"-- +*- - -ji
s$ s3\q".1| ;',.-l} ".'i)il irQ-Jt\\'*
3"i $ iTii[iiJ i;3,ij]i"$'t ISi:p'i*i tul ,tj''6-isii
rg$_}
\3i\_\!ll?er-C
